OverviewSuggest Edit

Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. The company uses new building blocks to create proteins that impart specificity not possible with native proteins. 

TypePublic
Founded2014
HQSan Diego, CA, US
Websitesynthorx.com

Latest Updates

Employees (est.) (Mar 2019)39(+40%)
Share Price (Jan 2020)$68
Cybersecurity ratingAMore

Key People/Management at Synthorx

Marcos Milla

Marcos Milla

Chief Scientific Officer
Lauren Baker Ph

Lauren Baker Ph

VP, Scientific Affairs and Communications
Eric Miller

Eric Miller

Senior Director, Finance
Floyd Romesberg

Floyd Romesberg

Founder and Distinguished Fellow
Lilia Koriazova

Lilia Koriazova

Director, Preclinical Development
Jerod Ptacin

Jerod Ptacin

Senior Director of Platform and Target Development
Show more

Synthorx Office Locations

Synthorx has an office in San Diego
San Diego, CA, US (HQ)
11099 N Torrey Pines Rd #290, La Jolla
Show all (1)

Synthorx Financials and Metrics

Synthorx Revenue

USD

Net income (Q3, 2019)

(12.2m)

EBIT (Q3, 2019)

(13.2m)

Market capitalization (23-Jan-2020)

2.2b

Closing stock price (23-Jan-2020)

68.0

Cash (30-Sept-2019)

18.5m

EV

2.2b
Synthorx's current market capitalization is $2.2 b.
Annual
USDFY, 2016FY, 2017

General and administrative expense

1.2m1.9m

R&D expense

1.9m3.9m

Operating expense total

3.1m5.9m

EBIT

(3.1m)(5.8m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019

General and administrative expense

2.4m3.0m3.0m

R&D expense

9.6m10.4m10.2m

Operating expense total

11.9m13.5m13.2m

EBIT

(11.9m)(13.5m)(13.2m)
Annual
USDFY, 2016FY, 2017

Cash

4.1m3.7m

Prepaid Expenses

15.0k66.0k

Current Assets

4.1m3.7m

PP&E

431.0k692.0k
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

57.8m41.7m23.5m18.5m

Prepaid Expenses

135.0k1.3m3.6m6.8m

Current Assets

57.9m180.7m168.7m157.7m

PP&E

1.3m1.4m1.6m2.0m
Annual
USDFY, 2016FY, 2017

Net Income

(3.1m)(5.8m)

Depreciation and Amortization

32.0k114.0k

Cash From Operating Activities

(2.8m)(5.1m)

Purchases of PP&E

(403.0k)(388.0k)
Quarterly
USDQ3, 2017Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(3.7m)(28.4m)(10.9m)(23.2m)(35.4m)

Depreciation and Amortization

76.0k162.0k93.0k194.0k305.0k

Accounts Payable

775.0k(5.0k)1.2m

Cash From Operating Activities

(3.1m)(9.3m)(9.4m)(24.5m)(38.9m)
USDFY, 2016

Financial Leverage

-0.7 x
Show all financial metrics

Synthorx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

98/100

SecurityScorecard logo

Synthorx Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Synthorx Online and Social Media Presence

Embed Graph

Synthorx News and Updates

Sanofi Completes Acquisition of Synthorx, Inc.

PARIS, Jan. 23, 2020 /PRNewswire/ -- Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in cash. "The acquisition of Synthorx perfectly aligns with our R&D strategy, enhancing our position as an...

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.

Sanofi Completes Acquisition of Synthorx, Inc. 

UPDATE 2-France's Sanofi to buy biotech firm Synthorx for $2.5 bln

France's Sanofi on Monday agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion as it steps up a push in the lucrative field of cancer drugs under its new chief executive.

France's Sanofi to buy biotech firm Synthorx for $2.5 billion

Sanofi said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker's pipeline of drugs for cancer and auto-immune disorders.
Show more

Synthorx Frequently Asked Questions

  • When was Synthorx founded?

    Synthorx was founded in 2014.

  • Who are Synthorx key executives?

    Synthorx's key executives are Marcos Milla, Lauren Baker Ph and Eric Miller.

  • How many employees does Synthorx have?

    Synthorx has 39 employees.

  • Who are Synthorx competitors?

    Competitors of Synthorx include Neopharmed Gentili, Macopharma and Heron Therapeutics.

  • Where is Synthorx headquarters?

    Synthorx headquarters is located at 11099 N Torrey Pines Rd #290, La Jolla, San Diego.

  • Where are Synthorx offices?

    Synthorx has an office in San Diego.

  • How many offices does Synthorx have?

    Synthorx has 1 office.